Bullock Wealth Management’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Buy
40,218
+11,821
+42% +$298K 0.44% 58
2026
Q1
$715K Buy
28,397
+11,394
+67% +$291K 0.36% 69
2025
Q4
$434K Buy
17,003
+12,805
+305% +$328K 0.21% 97
2025
Q3
$108K Buy
4,198
+2,361
+129% +$59.9K 0.05% 208
2025
Q2
$46.2K Buy
+1,837
New +$45.6K 0.02% 249

Other funds holding IBDX

Bullock Wealth Management's IBDX Position: Q2 2026 in Review

Bullock Wealth Management increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 42% in Q2 2026, buying an estimated $298K and bringing the position to 40,218 shares worth $1.01M. The position accounts for 0.44% of the portfolio, ranked #58.

Bullock Wealth Management first reported a position in IBDX in Q2 2025 and has held it in 5 quarters since. 229 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Bullock Wealth Management held 40,218 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $1.01M as of Q2 2026.
  • Bullock Wealth Management bought 11,821 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $298K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.44% of Bullock Wealth Management's portfolio in Q2 2026, its #58 holding.
  • Bullock Wealth Management first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q2 2025 and has held it in 5 quarters since.
  • 229 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Bullock Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.